SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-12-000012
Filing Date
2012-01-03
Accepted
2012-01-03 15:26:37
Documents
1
Period of Report
2012-01-01

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 5863
  Complete submission text file 0001171843-12-000012.txt   7352
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Issuer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1275 W. WASHINGTON TEMPE AZ 85281
Business Address
WHITE AUGUSTUS A (Reporting) CIK: 0001191705 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33560 | Film No.: 12501726